Total Payments
$14,427
2024 Payments
$559.00
Companies
29
Transactions
322
Medicare Patients
6,942
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$11,127 (77.1%)
Travel$3,300 (22.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,127 | 309 | 77.1% |
| Travel and Lodging | $3,300 | 13 | 22.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $5,596 | 168 | $0 (2024) |
| Medtronic USA, Inc. | $3,950 | 47 | $0 (2020) |
| Nevro Corp. | $901.01 | 14 | $0 (2024) |
| SI-BONE, INC. | $818.21 | 9 | $0 (2023) |
| Vertos Medical, Inc. | $717.27 | 12 | $0 (2024) |
| Boston Scientific Corporation | $676.45 | 9 | $0 (2024) |
| Medtronic, Inc. | $370.43 | 9 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $255.93 | 14 | $0 (2024) |
| Vertiflex, Inc. | $255.90 | 2 | $0 (2018) |
| GRT US Holding, Inc. | $150.03 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $559.00 | 23 | Boston Scientific Corporation ($158.82) |
| 2023 | $1,181 | 53 | Abbott Laboratories ($494.11) |
| 2022 | $682.10 | 20 | Vertos Medical, Inc. ($282.42) |
| 2021 | $2,091 | 57 | Abbott Laboratories ($824.19) |
| 2020 | $2,330 | 66 | Abbott Laboratories ($1,402) |
| 2019 | $3,778 | 67 | Abbott Laboratories ($1,706) |
| 2018 | $3,200 | 22 | Medtronic USA, Inc. ($2,171) |
| 2017 | $605.69 | 14 | Abbott Laboratories ($381.73) |
All Payment Transactions
322 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Neuromodulation | ||||||
| 12/18/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $158.82 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/05/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.45 | General |
| Category: Opioid Analgesic | ||||||
| 12/05/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Neuromodulation | ||||||
| 10/23/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Neuromodulation | ||||||
| 10/21/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $27.15 | General |
| 10/03/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.80 | General |
| Category: Opioid Analgesic | ||||||
| 08/12/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $43.63 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/01/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.93 | General |
| Category: Opioid Analgesic | ||||||
| 07/03/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/01/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Neuromodulation | ||||||
| 06/10/2024 | Electronic Waveform Lab, Inc. | — | Food and Beverage | Cash or cash equivalent | $30.56 | General |
| 06/07/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: Neuromodulation | ||||||
| 05/22/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $14.97 | General |
| Category: Opioid Analgesic | ||||||
| 05/20/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: Drug Infusion Systems | ||||||
| 05/16/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Orthopedic | ||||||
| 05/01/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Neuromodulation | ||||||
| 04/10/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Insomnia | ||||||
| 04/05/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Neuromodulation | ||||||
| 03/13/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Neuromodulation | ||||||
| 03/01/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Neuromodulation | ||||||
| 01/08/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Neuromodulation | ||||||
| 01/08/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: Neuromodulation | ||||||
| 12/06/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.99 | General |
| Category: Opioid Analgesic | ||||||
| 12/04/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,033 | 2,972 | $1.8M | $300,809 |
| 2022 | 21 | 1,738 | 2,902 | $1.7M | $301,066 |
| 2021 | 17 | 1,368 | 4,401 | $2.6M | $204,847 |
| 2020 | 18 | 1,803 | 4,888 | $2.8M | $235,964 |
Total Patients
6,942
Total Services
15,163
Medicare Billing
$1.0M
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 355 | 909 | $546,000 | $88,539 | 16.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 300 | 301 | $234,860 | $39,208 | 16.7% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 135 | 165 | $146,850 | $32,137 | 21.9% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 73 | 78 | $98,280 | $16,941 | 17.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 96 | 147 | $89,720 | $15,557 | 17.3% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 197 | 252 | $70,560 | $15,225 | 21.6% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 87 | 92 | $64,400 | $14,118 | 21.9% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 95 | 112 | $59,280 | $10,284 | 17.3% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 55 | 84 | $56,690 | $9,640 | 17.0% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 95 | 146 | $50,900 | $8,733 | 17.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 86 | 108 | $92,020 | $8,691 | 9.4% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 91 | 97 | $44,920 | $7,800 | 17.4% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 33 | 41 | $41,940 | $7,322 | 17.5% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 73 | 91 | $34,110 | $5,930 | 17.4% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 55 | 84 | $31,600 | $5,441 | 17.2% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 91 | 107 | $25,800 | $4,503 | 17.5% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 33 | 65 | $23,210 | $4,043 | 17.4% |
| 77002 | Fluoroscopic guidance for needle placement | Facility | 2023 | 33 | 35 | $19,600 | $3,407 | 17.4% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 18 | 21 | $25,050 | $1,829 | 7.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 32 | 37 | $8,650 | $1,461 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 510 | 1,321 | $820,240 | $125,335 | 15.3% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 260 | 348 | $309,720 | $68,349 | 22.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 275 | 370 | $103,600 | $22,711 | 21.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 180 | 180 | $147,600 | $22,492 | 15.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 48 | 74 | $46,860 | $7,700 | 16.4% |
About Dr. Greesh John, M.D
Dr. Greesh John, M.D is a Interventional Pain Medicine healthcare provider based in Easton, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2010. The National Provider Identifier (NPI) number assigned to this provider is 1922316272.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Greesh John, M.D has received a total of $14,427 in payments from pharmaceutical and medical device companies, with $559.00 received in 2024. These payments were reported across 322 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($11,127).
As a Medicare-enrolled provider, John has provided services to 6,942 Medicare beneficiaries, totaling 15,163 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Pain Medicine
- Location Easton, MD
- Active Since 09/21/2010
- Last Updated 12/01/2021
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1922316272
Products in Payments
- Proclaim Family of SCS IPGs (Device) $2,933
- KYPHON Balloon Kyphoplasty (Device) $2,109
- INTELLIS (Device) $1,588
- Senza Spinal Cord Stimulation System (Device) $751.66
- Proclaim IPG (Device) $742.41
- mild Device Kit (Device) $717.27
- PROCLAIM (Device) $705.77
- iFuse Implant (Device) $667.46
- SCS IPGs (Device) $467.72
- WaveWriter Alpha Prime 16 (Device) $305.21
- Axium INS DRG IPG (Device) $269.67
- Superion ISS (Device) $255.90
- VERTIFLEX SUPERION (Device) $210.37
- MYSTIM (Device) $197.77
- VECTRIS (Device) $190.71
- Qutenza (Drug) $150.03
- DRG IPGs (Device) $143.72
- BIOTRONIK (Device) $143.65
- XTAMPZA (Drug) $134.59
- GENERAL - PAIN MANAGEMENT (Device) $125.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.